| 000 | 01711 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516115217.0 | ||
| 264 | 0 | _c20130117 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1423-0232 | ||
| 024 | 7 |
_a10.1159/000342425 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoschny, Ronald | |
| 245 | 0 | 0 |
_aDiarrhea is a positive outcome predictor for sorafenib treatment of advanced hepatocellular carcinoma. _h[electronic resource] |
| 260 |
_bOncology _c2013 |
||
| 300 |
_a6-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBenzenesulfonates _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xcomplications |
| 650 | 0 | 4 |
_aDiarrhea _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xcomplications |
| 650 | 0 | 4 |
_aLiver Neoplasms _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPyridines _xtherapeutic use |
| 650 | 0 | 4 |
_aSkin Diseases _xchemically induced |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 700 | 1 | _aGotthardt, Daniel | |
| 700 | 1 | _aKoehler, Christiane | |
| 700 | 1 | _aJaeger, Dirk | |
| 700 | 1 | _aStremmel, Wolfgang | |
| 700 | 1 | _aGanten, Tom M | |
| 773 | 0 |
_tOncology _gvol. 84 _gno. 1 _gp. 6-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000342425 _zAvailable from publisher's website |
| 999 |
_c22192727 _d22192727 |
||